1 cm and 4) mediastinal pleural involvement. Involvement of a multidisciplinary team is recommended to ensure prompt and appropriate management, using a framework of radiotherapy, chemotherapy, surgery and symptom palliation with end of life care. Compensation issues must also be considered. Life expectancy in malignant mesothelioma is poor, with a median survival of about one year following diagnosis." /> 1 cm and 4) mediastinal pleural involvement. Involvement of a multidisciplinary team is recommended to ensure prompt and appropriate management, using a framework of radiotherapy, chemotherapy, surgery and symptom palliation with end of life care. Compensation issues must also be considered. Life expectancy in malignant mesothelioma is poor, with a median survival of about one year following diagnosis." />

Orphanet Journal of Rare Diseases

official impact factor 5.93

Open Access Highly Access Review

Malignant mesothelioma

Alastair J Moore*, Robert J Parker and John Wiggins

Orphanet Journal of Rare Diseases 2008, 3:34 doi:10.1186/1750-1172-3-34

No comments have yet been made on this article.

Post a comment